These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34856968)

  • 1. Short-term functional outcome in psychotic patients: results of the Turku early psychosis study (TEPS).
    Salokangas RKR; From T; Ilonen T; Luutonen S; Heinimaa M; Armio RL; Laurikainen H; Walta M; Paju J; Toivonen A; Jalo P; Tuominen L; Hietala J
    BMC Psychiatry; 2021 Dec; 21(1):602. PubMed ID: 34856968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project.
    Salokangas RK; Heinimaa M; From T; Löyttyniemi E; Ilonen T; Luutonen S; Hietala J; Svirskis T; von Reventlow HG; Juckel G; Linszen D; Dingemans P; Birchwood M; Patterson P; Schultze-Lutter F; Ruhrmann S; Klosterkötter J;
    Eur Psychiatry; 2014 Aug; 29(6):371-80. PubMed ID: 24315804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.
    Morcillo C; Stochl J; Russo DA; Zambrana A; Ratnayake N; Jones PB; Perez J
    Psychopathology; 2015; 48(2):120-6. PubMed ID: 25720419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When to initiate antipsychotic treatment for psychotic symptoms: At the premorbid phase or first episode of psychosis?
    Zhang T; Xu L; Wei Y; Tang X; Hu Y; Cui H; Tang Y; Xie B; Li C; Wang J
    Aust N Z J Psychiatry; 2021 Mar; 55(3):314-323. PubMed ID: 33143440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis.
    Del Rey-Mejías Á; Fraguas D; Díaz-Caneja CM; Pina-Camacho L; Castro-Fornieles J; Baeza I; Espliego A; Merchán-Naranjo J; González-Pinto A; de la Serna E; Payá B; Graell M; Arango C; Parellada M
    Eur Child Adolesc Psychiatry; 2015 Dec; 24(12):1447-59. PubMed ID: 25726022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Adverse Outcomes With Emotion Processing and Its Neural Substrate in Individuals at Clinical High Risk for Psychosis.
    Modinos G; Kempton MJ; Tognin S; Calem M; Porffy L; Antoniades M; Mason A; Azis M; Allen P; Nelson B; McGorry P; Pantelis C; Riecher-Rössler A; Borgwardt S; Bressan R; Barrantes-Vidal N; Krebs MO; Nordentoft M; Glenthøj B; Ruhrmann S; Sachs G; Rutten B; van Os J; de Haan L; Velthorst E; van der Gaag M; Valmaggia LR; McGuire P;
    JAMA Psychiatry; 2020 Feb; 77(2):190-200. PubMed ID: 31722018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Learning to trust: social feedback normalizes trust behavior in first-episode psychosis and clinical high risk.
    Lemmers-Jansen ILJ; Fett AJ; Hanssen E; Veltman DJ; Krabbendam L
    Psychol Med; 2019 Apr; 49(5):780-790. PubMed ID: 29897026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
    Lyngberg K; Buchy L; Liu L; Perkins D; Woods S; Addington J
    Schizophr Res; 2015 Dec; 169(1-3):209-213. PubMed ID: 26589390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterising cognitive heterogeneity in individuals at clinical high-risk for psychosis: a cluster analysis with clinical and functional outcome prediction.
    Haining K; Gajwani R; Gross J; Gumley AI; Ince RAA; Lawrie SM; Schultze-Lutter F; Schwannauer M; Uhlhaas PJ
    Eur Arch Psychiatry Clin Neurosci; 2022 Apr; 272(3):437-448. PubMed ID: 34401957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis.
    Hauser M; Zhang JP; Sheridan EM; Burdick KE; Mogil R; Kane JM; Auther A; Carrión RE; Cornblatt BA; Correll CU
    J Clin Psychiatry; 2017 Jan; 78(1):e28-e40. PubMed ID: 28129494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [What support of young presenting a first psychotic episode, when schooling is being challenged?].
    Vacheron MN; Veyrat-Masson H; Wehbe E
    Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood trauma and premorbid adjustment among individuals at clinical high risk for psychosis and normal control subjects.
    Tikka M; Luutonen S; Ilonen T; Tuominen L; Kotimäki M; Hankala J; Salokangas RK
    Early Interv Psychiatry; 2013 Feb; 7(1):51-7. PubMed ID: 22925391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Pre-onset Subthreshold Psychotic Symptoms With Longitudinal Outcomes During Treatment of a First Episode of Psychosis.
    Rosengard RJ; Malla A; Mustafa S; Iyer SN; Joober R; Bodnar M; Lepage M; Shah JL
    JAMA Psychiatry; 2019 Jan; 76(1):61-70. PubMed ID: 30304442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive reserve as a moderator of outcomes in five clusters of first episode psychosis patients: a 10-year follow-up study of the PAFIP cohort.
    Ayesa-Arriola R; de la Foz VO; Murillo-García N; Vázquez-Bourgon J; Juncal-Ruiz M; Gómez-Revuelta M; Suárez-Pinilla P; Setién-Suero E; Crespo-Facorro B
    Psychol Med; 2023 Apr; 53(5):1891-1905. PubMed ID: 37310335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort.
    Braun A; Liu L; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J
    Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1379-1388. PubMed ID: 35113189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotic symptoms, cognition and affect as predictors of psychosocial problems and functional change in first-episode psychosis.
    Stouten LH; Veling W; Laan W; van der Helm M; van der Gaag M
    Schizophr Res; 2014 Sep; 158(1-3):113-9. PubMed ID: 25008791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forecasting prognostic trajectories with mismatch negativity in early psychosis.
    Kim M; Kim T; Hwang WJ; Lho SK; Moon SY; Lee TY; Kwon JS
    Psychol Med; 2023 Mar; 53(4):1489-1499. PubMed ID: 36315242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study.
    Fraguas D; Del Rey-Mejías A; Moreno C; Castro-Fornieles J; Graell M; Otero S; Gonzalez-Pinto A; Moreno D; Baeza I; Martínez-Cengotitabengoa M; Arango C; Parellada M
    Schizophr Res; 2014 Jan; 152(1):130-8. PubMed ID: 24332406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.